© Fraunhofer IZI
Here we show you a selection of current projects.
The unit aims to develop cell-therapeutic methods and antibody-based therapeutic strategies (immuno-oncology) for the treatment of hematologic-oncologic diseases (e.g. leukemia) and complications resulting from hematopoietic stem cell transplantations (e.g. Graft-versus-Host-Disease, GvHD). The unit also explores innovative therapeutic approaches for the prevention of infections, especially those caused by multiresistant pathogens in the case of transplantations. New immune tolerance concepts are also tested in models developed by the unit, with regard to immunological and therapy-associated complications.